Spero Therapeutics, Inc. (SPRO)
2.79
+0.03
(+1.09%)
USD |
NASDAQ |
May 15, 16:00
2.795
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Profit Margin (Quarterly) : -2.79K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -- |
| Lantern Pharma, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Amgen, Inc. | 21.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 37.14% |
| Return on Assets | 23.66% |
| Return on Invested Capital | 34.41% |
| Operating Margin (Quarterly) | -2.92K% |
| Return on Net Operating Assets | 90.55% |